Business Wire

IBC Best Conference Paper Award Recognises Advances in Artificial Intelligence

Jaa

In a year when artificial intelligence and machine learning became a very hot topic in the media industry, the IBC Best Conference Paper Award goes to a team from BBC R&D which has investigated practical applications. The award is made to the technical paper which, according to the team of peer reviewers, delivers not just the most significant new research, but does so in an accessible way.

The paper, ‘AI in production: video analysis and machine learning for expanded live events coverage’, will be presented at midday on Sunday 16 September as part of a new initiative at IBC2018 – ‘Tech Talks’. ‘Tech Talks’ ensures that the highly respected technical papers remain an integral part of IBC and its conference, bringing the latest ideas to all delegates in a fresh and accessible form.

Talking of the new innovation, Dr Nick Lodge, executive producer of technical sessions in the conference, said “Senior technologists and researchers who have been responsible for original and thought-provoking advances in media technology will talk about their own work, and audiences will have the rare opportunity to question these world experts.

“The technologies that impact the media industry are broad,” he added. “This year’s ‘Tech Talks’ will cover emerging areas like artificial intelligence, virtual and augmented reality, 5G and blockchain.”

In the award-winning paper a team of BBC researchers covering a wide range of skills, under project lead Mike Evans, discuss a project known as ‘Ed’. This prototype system is used to create near-live content with minimal crew. An example might be a set of three unmanned 4K cameras, from which ‘Ed’ would produce a number of properly framed HD pictures, cutting between them as appropriate.

“The point of the work is to allow coverage of more events, to reach places we otherwise could not reach,” Mike Evans said. “With conventional production we cover only about six of the nearly 100 places music is performed at the Glastonbury Festival, for example, or just a tiny fraction of the 50,000 performances in 300 venues at the Edinburgh Fringe.”

“But with ‘Ed’ we can reach many more of these and do so with production techniques which are much less intrusive for the event itself,” he explained. “This technology will be suitable not just for major production companies like the BBC, but for a whole range of use cases, like minor sports which need to increase visibility, and even vloggers who want to improve their online presence.”

Dr Paul Entwistle, Chair of the IBC Technical Papers Committee which provides careful peer review of the many papers proposed for IBC, said “The detail in this paper is absolutely fascinating. The team has developed an artificial intelligence system that understands the rhythms and cadences that make for professional video production. This was validated by research to see how well ‘Ed’ performs compared with a real director, and how the audience perceived the viewing experience.”

The authors winning this year’s IBC Best Conference Paper are Craig Wright (who will be presenting it at IBC), Jack Allnut, Rosie Campbell, Michael Evans, Ronan Forman, James Gibson, Stephen Jolly, Lianne Kerlin, Zuzanna Lechelt, Graeme Phillipson and Matthew Shotton, all from BBC R&D. They will be presented with the award as part of the IBC Awards Ceremony, on Sunday evening 16 September at 18:30 in the Auditorium.

The ceremony will see the presentation of all of IBC’s awards, including the International Honour for Excellence. Attendance is free for all IBC visitors.

## ENDS ##

Notes to Editors:

For more information about IBC2018 visit: show.ibc.org

About IBC
IBC is the world’s most influential media, entertainment and technology show. It attracts 57,000+ attendees from more than 170 countries and combines a highly respected and peer-reviewed conference with an exhibition that showcases more than 1,700 leading suppliers of state-of-the-art electronic media and entertainment technology.

IBC2018 Dates
Conference: 13 - 17 September 2018

Exhibition: 14 - 18 September 2018

For more information about IBC2018 visit: show.ibc.org/

Contact information

IBC
Louise Wells, Bubble Agency
E: louisew@bubbleagency.com
T: +44 7718 985 252

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 13:49Tiedote

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme